Safety issues and concerns of new immunomodulators in rheumatology
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14740338.2015.993605
Reference97 articles.
1. Safety of biologic therapy in rheumatoid arthritis
2. Screening of tuberculosis before biologics
3. Tumor Necrosis Factor and Tuberculosis
4. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
5. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials;Arthritis Research & Therapy;2024-02-12
2. Efficacy and Safety of Secukinumab for the Treatment of Psoriasis: A Meta-Analysis of Pivotal Phase III Trials;Dermatology;2023-11-03
3. Évènements indésirables infectieux chez des enfants atteints d’arthrite juvénile idiopathique et traités en vie réelle par biothérapies : données issues de la JIR cohorte;Revue du Rhumatisme;2021-12
4. Diagnostic predictability of miR-4535 and miR-1915–5p expression in amniotic fluid for foetal morbidity of infection;Placenta;2021-10
5. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry;Annals of the Rheumatic Diseases;2021-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3